Skip to main content

News Archive


Browse Our News Archive

November, 1-30, 2017

Mary E. Hatten honored with the Ralph W. Gerard Prize in Neuroscience

Mary E. Hatten, a neuroscientist who studies the mechanisms of neuronal differentiation and migration during the early stages of embryonic development, has been awarded the 2017 Ralph W. Gerard Prize in Neuroscience. The $25,000 prize, given annually by the Society for Neuroscience, honors an outstanding scientist who has made significant…...

New study points the way to therapy for rare cancer that targets the young

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults. Sanford Simon, who conducted…...

In the fight against viral infection, spelling counts

For millions of years, humans and viruses have engaged in a constant tug of war: as our cells evolve new ways to defend us from our viral enemies, these pathogens in turn acquire new traits to sidestep those defenses. Now, scientists have found that a key similarity between our genes…...

Targeting a single protein might treat a broad range of viruses

Most drugs that fight viruses are designed to target individual pathogens. But scientists at The Rockefeller University have identified a protein that a broad range of viruses require to spread within a host—a discovery that could lead to fighting viruses as varied as parainfluenza, West Nile, and Zika with a…...

Potential new treatment for Fragile X targets one gene to affect many

In Fragile X Syndrome—the leading genetic form of intellectual disability and autism—the effects of a single defective gene ripple through a series of chemical pathways, altering signals between brain cells. It’s a complex condition, but new research from Rockefeller University finds that inhibiting a regulatory protein alters the intricate signaling…...